Abbott Laboratories (NYSE:ABT) Price Target Raised to $137.00 at Jefferies Financial Group
Abbott Laboratories (NYSE:ABT – Get Free Report) had its price target increased by analysts at Jefferies Financial Group from $135.00 to $137.00 in a research note issued on Thursday,Benzinga reports. The firm presently has a “hold” rating on the healthcare product maker’s stock. Jefferies Financial Group’s target price indicates a potential upside of 4.58% from […]
Abbott Laboratories (NYSE:ABT – Get Free Report) had its price target increased by analysts at Jefferies Financial Group from $135.00 to $137.00 in a research note issued on Thursday,Benzinga reports. The firm presently has a “hold” rating on the healthcare product maker’s stock. Jefferies Financial Group’s target price indicates a potential upside of 4.58% from […]
